Zou Yang, Liu Fa-Ying, Wang Li-Qun, Guo Jiu-Bai, Yang Bi-Cheng, Wan Xi-Di, Wang Feng, He Ming, Huang Ou-Ping
Key Laboratory of Women's Reproductive Health of Jiangxi Province, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China; Central Laboratory, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China.
Key Laboratory of Women's Reproductive Health of Jiangxi Province, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China; Department of Gynecology, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China.
Gene. 2017 Mar 10;604:41-47. doi: 10.1016/j.gene.2016.12.011. Epub 2016 Dec 14.
Adenomyosis is a common benign gynecological condition in female reproductive tract and the detailed molecular etiology remains largely elusive. Previous studies implicated that deregulated expression of DNA (cytosine-5)-methyltransferase 3A (DNMT3A), a de novo DNA methyltransferase, might be involved in the pathogenesis of adenomyosis. Meanwhile, ectopic endometrial stromal cells (EESCs) were suggested to play crucial roles in adenomyosis. Herein, we evaluated the expression of DNMT3A protein in 36 ectopic endometriums with adenomyosis and 37 eutopic endometriums in controls with Western blotting (WB) or immunohistochemistry (IHC), we found that the expression of DNMT3A was significantly decreased in the ectopic endometriums and EESCs in adenomyosis relative to that of eutopic endometriums and EESCs in control samples, respectively. In addition, our functional assays revealed that overexpression of DNMT3A suppressed cell proliferation and invasion, while knockdown of DNMT3A enhanced cell proliferation and invasion in EESCs. Taken together, our results suggested that DNMT3A expression was decreased in ectopic endometriums and EESCs in adenomyosis, and we provided the first evidence that decreased DNMT3A expression in EESCs facilitated the development of adenomyosis via enhanced cell growth and invasion.
子宫腺肌病是女性生殖道常见的良性妇科疾病,其详细的分子病因仍不清楚。以往的研究表明,DNA(胞嘧啶-5)-甲基转移酶3A(DNMT3A),一种从头DNA甲基转移酶,其表达失调可能参与子宫腺肌病的发病机制。同时,异位子宫内膜间质细胞(EESCs)被认为在子宫腺肌病中起关键作用。在此,我们通过蛋白质印迹法(WB)或免疫组织化学(IHC)评估了36例子宫腺肌病异位内膜和37例对照正常内膜中DNMT3A蛋白的表达,我们发现相对于对照样本中的正常内膜和EESCs,子宫腺肌病异位内膜和EESCs中DNMT3A的表达分别显著降低。此外,我们的功能试验表明,DNMT3A的过表达抑制细胞增殖和侵袭,而敲低DNMT3A则增强EESCs中的细胞增殖和侵袭。综上所述,我们的结果表明子宫腺肌病异位内膜和EESCs中DNMT3A表达降低,并且我们提供了首个证据,即EESCs中DNMT3A表达降低通过增强细胞生长和侵袭促进子宫腺肌病的发展。